PharmaMar

NCT07839819

Phase 1/2Not yet recruiting2026231 people24 Sept 2026clinicaltrials.gov

NCT06524583

CollaboratorPhase 2Recruiting2025198 people29 Jul 2024clinicaltrials.gov

NCT06088290

Phase 3Active, not recruiting2023469 people18 Oct 2023clinicaltrials.gov

NCT04784559

Phase 3Terminated2021205 people5 Mar 2021clinicaltrials.gov

NCT03117361

Phase 2Terminated201710 people17 Apr 2017clinicaltrials.gov

NCT02566993

Phase 3Completed2016613 people2 Oct 2015clinicaltrials.gov

NCT02448537

CollaboratorPhase 2Completed201542 people19 May 2015clinicaltrials.gov

NCT02100657

Phase 1Completed201439 people1 Apr 2014clinicaltrials.gov

NCT01980667

Phase 1Completed201441 people11 Nov 2013clinicaltrials.gov

NCT01970540

Phase 1Completed2011122 people28 Oct 2013clinicaltrials.gov

NCT01846611

CollaboratorPhase 3Completed2013581 people3 May 2013clinicaltrials.gov

NCT01273493

CollaboratorPhase 1Completed201015 people10 Jan 2011clinicaltrials.gov

NCT01102426

Phase 3Completed2010255 people13 Apr 2010clinicaltrials.gov

NCT00796120

CollaboratorPhase 3Completed2008121 people24 Nov 2008clinicaltrials.gov

NCT00788099

Phase 1Completed200845 people10 Nov 2008clinicaltrials.gov

NCT00580112

CollaboratorPhase 2Completed2007127 people24 Dec 2007clinicaltrials.gov

NCT00579501

CollaboratorPhase 2Completed200729 people24 Dec 2007clinicaltrials.gov

NCT00113607

CollaboratorPhase 3Completed2005672 people10 Jun 2005clinicaltrials.gov

NCT00102609

CollaboratorPhase 1Completed200541 people1 Feb 2005clinicaltrials.gov

NCT00060944

CollaboratorPhase 2Completed2003271 people19 May 2003clinicaltrials.gov